| Quarterly Financials | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 313 | 376 | 409 | 312 | 372 | 391 | 354 | 302 | 422 | 296 | 222 | 251 | 251 | 353 | 301 | 240 |
| Expenses | 190 | 213 | 239 | 175 | 205 | 188 | 209 | 195 | 267 | 197 | 142 | 206 | 162 | 257 | 214 | 171 |
| EBITDA | 123 | 164 | 170 | 138 | 167 | 203 | 146 | 107 | 155 | 99 | 81 | 46 | 89 | 96 | 86 | 69 |
| Operating Profit % | 38 % | 43 % | 40 % | 40 % | 44 % | 51 % | 39 % | 33 % | 35 % | 31 % | 33 % | 14 % | 33 % | 26 % | 27 % | 27 % |
| Depreciation | 17 | 17 | 18 | 17 | 17 | 17 | 18 | 18 | 18 | 18 | 19 | 20 | 20 | 21 | 23 | 24 |
| Interest | 41 | 39 | 39 | 35 | 19 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 0 | 5 | 6 |
| Profit Before Tax | 66 | 107 | 113 | 86 | 131 | 182 | 125 | 87 | 135 | 80 | 61 | 23 | 66 | 75 | 58 | 40 |
| Tax | 17 | 25 | 28 | 22 | 33 | 46 | 31 | 21 | 34 | 22 | 16 | 7 | 18 | 21 | 18 | 11 |
| Net Profit | 49 | 82 | 84 | 64 | 98 | 137 | 94 | 66 | 102 | 58 | 45 | 16 | 48 | 54 | 40 | 29 |
| EPS in ₹ | 4.75 | 7.90 | 6.86 | 6.16 | 8.75 | 11.09 | 7.63 | 5.36 | 8.24 | 4.65 | 3.64 | 1.28 | 3.89 | 4.33 | 3.25 | 2.36 |
Archean Chemical Industries
Archean Chemical Industries
505.25
-6.65
(-1.30%)
Market Cap
₹6,236.18 Cr
PE Ratio
40.07
Volume
27,663.00
Day High - Low
₹511.90 - ₹502.00
52W High-Low
₹730.00 - ₹408.35
Key Fundamentals
Market Cap
6,236.18 Cr
EPS
13.13
PB Ratio
3.59
Book Value
154.20
EBITDA
351.40
Dividend Yield
0.54 %
Industry
Chemicals Sector
Specialty Chemicals ROE Growth %
-
Debt to Equity
0.09
Analyst Rating and Forecast
- By Refinitiv from4 analysts
Actual
Company News
View All News
Archean Chemical Industries reported Q2 FY26 revenue of INR 2,317.8 million (8% decline YoY) with bromine production challenges due to technical issues and prolonged monsoons, while achieving a major milestone with India Semiconductor Mission approval for its INR 2,067 crore SiC project. The company maintained healthy EBITDA margins at 33% and remains net debt-free, with H1 FY26 revenue growing 10% to INR 5,232 million despite operational headwinds in core bromine and industrial salt businesses.
Chemikas Speciality LLP Pledges 48 Lakh Shares of Archean Chemical IndustriesNov 19, 2025
Chemikas Speciality LLP has pledged 48,00,000 equity shares of Archean Chemical Industries Limited under SEBI takeover regulations. The disclosure affects the shareholding pattern and encumbrance status of the promoter entity in the listed chemical company.
Archaean Chemical Subsidiary Begins Construction of Silicon Carbide Semiconductor Facility in Bhubaneswar
Nov 17, 2025
Nov 17, 2025Archaean Chemical's subsidiary Sicsem Private Limited conducted a groundbreaking ceremony for a Silicon Carbide compound semiconductor fab and ATMP unit in Info Valley, Bhubaneswar, Odisha. The facility is scheduled to commence operations in November 2025, marking the company's expansion into semiconductor manufacturing.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,463.20 | #1 1,48,911.92 | 67.45 | 13,387.50 | 6.91 | #1 2,096 | 8.20 | 46.49 | |
2,870.00 | 85,073.92 | 52.26 | 14,825.80 | 12.13 | 1,251 | 92.75 | 53.26 | |
3,407.70 | 37,433.58 | 56.35 | 4,853.20 | 10.61 | 546 | 47.93 | 37.85 | |
5,775.00 | 29,571.33 | 68.99 | 2,393.10 | 12.83 | 289 | #1 152.38 | 54.36 | |
434.25 | 21,445.41 | 34.54 | 4,664.30 | 10.33 | 555 | 29.77 | 40.46 | |
1,519.30 | 20,722.19 | 43.74 | 8,365.80 | 7.84 | 697 | -38.83 | 14.87 | |
4,097.00 | 17,734.13 | 50.39 | #1 15,339.40 | 10.81 | 479 | -16.18 | 28.43 | |
5,756.00 | 16,946.67 | #1 31.74 | 5,692.40 | #1 18.99 | 499 | 30.75 | 40.62 | |
1,577.00 | 16,348.07 | 38.55 | 2,292.50 | 18.24 | 405 | 10.06 | 29.91 | |
1,217.30 | 13,858.75 | 60.16 | 1,448.50 | -3.77 | 160 | 86.93 | 67.49 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-21.49 %
Net Income Growth
-49.18 %
Cash Flow Change
-53.54 %
ROE
-53.60 %
ROCE
-53.44 %
EBITDA Margin (Avg.)
-11.54 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,531 | 1,755 | 2,056 | 2,393 |
| Fixed Assets | 1,086 | 1,110 | 1,160 | 1,378 |
| Current Assets | 399 | 577 | 726 | 691 |
| Capital Work in Progress | 17 | 36 | 48 | 69 |
| Investments | 11 | 210 | 350 | 339 |
| Other Assets | 417 | 399 | 498 | 607 |
| Total Liabilities | 1,531 | 1,755 | 2,056 | 2,393 |
| Current Liabilities | 176 | 172 | 135 | 197 |
| Non Current Liabilities | 1,093 | 152 | 219 | 332 |
| Total Equity | 262 | 1,431 | 1,702 | 1,864 |
| Reserve & Surplus | 239 | 1,406 | 1,677 | 1,839 |
| Share Capital | 19 | 25 | 25 | 25 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -19 | -6 | 40 | -5 |
| Investing Activities | -110 | -290 | -307 | -246 |
| Operating Activities | 315 | 496 | 379 | 176 |
| Financing Activities | -224 | -212 | -33 | 65 |
Share Holding
| % Holding | Feb 2022 | Nov 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 70.30 % | 53.60 % | 53.60 % | 53.60 % | 53.60 % | 53.60 % | 53.45 % | 53.45 % | 53.45 % | 53.45 % | 53.44 % | 53.44 % | 53.44 % | 53.44 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 5.86 % | 9.53 % | 10.17 % | 10.65 % | 10.94 % | 11.05 % | 11.15 % |
| DIIs | 0.00 % | 27.03 % | 29.79 % | 30.26 % | 17.78 % | 17.29 % | 18.83 % | 27.20 % | 21.12 % | 22.01 % | 22.85 % | 23.18 % | 24.68 % | 25.52 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 7.21 % | 3.67 % | 3.89 % | 4.86 % | 5.85 % | 7.12 % | 8.63 % | 10.10 % | 10.30 % | 9.69 % | 9.52 % | 8.41 % | 7.84 % |
| Others | 29.70 % | 12.16 % | 12.94 % | 12.25 % | 23.75 % | 23.26 % | 20.60 % | 4.84 % | 5.80 % | 4.07 % | 3.37 % | 2.93 % | 2.42 % | 2.06 % |
| No of Share Holders | 7 | 1,10,608 | 49,606 | 48,507 | 62,548 | 73,821 | 92,571 | 1,06,788 | 98,762 | 95,999 | 94,958 | 85,856 | 75,697 | 70,852 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.5 | 3 | 3 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.37 | 0.58 | 0.59 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 07 Jan 2022 |  Change Of Name | NA | 07 Jan 2022 | 0.00 | 0.00 |
| 21 Jul 2023 |  Dividend | ₹ 2.50 /share | 21 Jul 2023 | 532.50 | 529.90 |
| 17 Nov 2023 | Dividend | ₹ 1.00 /share | 17 Nov 2023 | 595.35 | 530.70 |
| 14 Feb 2024 | Dividend | ₹ 1.00 /share | 14 Feb 2024 | 619.50 | 651.85 |
| 21 Jun 2024 | Dividend | ₹ 1.00 /share | 21 Jun 2024 | 633.85 | 695.50 |
| 28 Jun 2024 |  Annual General Meeting | NA | 28 Jun 2024 | 633.85 | 657.40 |
| 08 Nov 2024 |  Quarterly Result Announcement | NA | 08 Nov 2024 | 653.60 | 685.65 |
| 07 Feb 2025 | Quarterly Result Announcement | NA | 07 Feb 2025 | 548.00 | 544.35 |
| 02 May 2025 | Quarterly Result Announcement | NA | 02 May 2025 | 640.25 | 626.35 |
| 26 May 2025 | Dividend | ₹ 3.00 /share | 26 May 2025 | 626.35 | 622.50 |
| 02 Jun 2025 | Annual General Meeting | NA | 02 Jun 2025 | 626.35 | 626.00 |
| 28 Jul 2025 | Quarterly Result Announcement | NA | 28 Jul 2025 | 697.65 | 677.60 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 634.60 | 631.40 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript10 days ago
10 days agoDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Nov 19, 2025
Nov 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 18, 2025
Nov 18, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Nov 15, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 14, 2025
Nov 14, 2025Board Meeting Outcome for Board Meeting Outcome 14.11.2025Nov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 13, 2025
Nov 13, 2025Board Meeting Intimation for Intimation Of Board MeetingNov 10, 2025
Nov 10, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011Nov 06, 2025
Nov 06, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Nov 01, 2025
Nov 01, 2025Announcement Under Regulation 30 (LODR)Nov 01, 2025
Nov 01, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Oct 09, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011Sep 29, 2025
Sep 29, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Sep 27, 2025
Sep 27, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Credit RatingSep 19, 2025
Sep 19, 2025Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 09, 2025
Sep 09, 2025Union Cabinet Approves Compound Semiconductor Fab Of Sicsem Private Limited (Subsidiary Of Archean Chemical Industries Limited)Aug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2025
Jul 31, 2025Earnings Call RecordingJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 30, 2025
Jul 30, 2025Intimation Of Newspaper PublicationJul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 28, 2025
Jul 28, 2025Board Meeting Outcome for Board Meeting Outcome 28.07.2025Jul 28, 2025
Jul 28, 2025Board Meeting Outcome for Board Meeting Outcome 28.07.2025Jul 28, 2025
Jul 28, 2025Board Meeting Intimation for Intimation Of Board MeetingJul 21, 2025
Jul 21, 2025Corporate GuaranteeJul 15, 2025
Jul 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Jul 09, 2025Loan To SubsidiaryJun 26, 2025
Jun 26, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jun 24, 2025
Jun 24, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJun 02, 2025
Jun 02, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJun 02, 2025
Jun 02, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
May 23, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 22, 2025
May 22, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 13, 2025
May 13, 2025Business Responsibility and Sustainability Reporting (BRSR)May 12, 2025
May 12, 2025Annual Report 2024-25 Including 16Th AGM Notice And BRSRMay 11, 2025
May 11, 2025Intimation Of The 16Th AGM Of The CompanyMay 11, 2025
May 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 07, 2025
May 07, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 06, 2025
May 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 05, 2025
May 05, 2025Intimation Of Newspaper PublicationMay 05, 2025
May 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 04, 2025
May 04, 2025Corporate Action-Board approves DividendMay 03, 2025
May 03, 2025Board Meeting Outcome for Revised Outcome - Corrigendum To The Board Meeting Outcome Regarding Final DividendMay 03, 2025
May 03, 2025Appointment Of Secretarial AuditorMay 03, 2025
May 03, 2025Mutual Fund Holdings
ICICI Prudential Multicap Fund Direct Plan-Growth 
Baroda BNP Paribas Multi Cap Fund Direct-Growth 
Mahindra Manulife Multi Asset Allocation Fund Direct - Growth 
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth 
Groww Nifty Total Market Index Fund Direct - Growth 
Angel One Nifty Total Market Index Fund Direct - Growth 
Bandhan Nifty Total Market Index Fund Direct-Growth 
Mirae Asset Nifty Total Market Index Fund Direct-Growth 
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth 
DSP Small Cap Direct Plan-Growth 
HDFC BSE 500 Index Fund Direct - Growth Technical Indicators
About Archean Chemical Industries
Archean Chemical Industries Limited is an Indian specialty marine chemical manufacturer. The company produces and exports bromine, industrial salt, and sulphate of potash from brine reserves in the Rann of Kutch, Gujarat. Their integrated production facility is located near Hajipir, Gujarat, spanning approximately 240 sq.km. The facility is connected to the Jakhau Jetty and Mundra Port for international transportation. Archean's products have applications in various industries including pharmaceuticals, agrochemicals, water treatment, flame retardants, chemical production, and fertilizers. As of 2021, the company's manufacturing facility had an installed capacity of 28,500 MT per annum of bromine, 3,000,000 MT per annum of industrial salt, and 130,000 MT per annum of sulphate of potash. The company completed a public issue in November 2022, raising Rs. 2420 crores.
Listing Date
21 Nov, 2022(3 Years,
-19 days)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
